Edstrom Hakan

Avg. Two Year Performance

30% Avg. Purchase Return
14% Compound
70% Avg. Sale Return
30% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return9%(7%)17%14%30%
Purchase Success Rate2 of 31 of 32 of 32 of 32 of 3
Average Sale Return8%17%53%68%70%
Sale Success Rate4 of 64 of 66 of 66 of 66 of 6
Drugs » Biotechnology

President & CEO, Director:

Holdings: 1.11M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 1.34K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--